Baculovirus as a gene delivery vector: Recent understandings of molecular alterations in transduced cells and latest applications

被引:112
作者
Chen, Chi-Yuan [1 ]
Lin, Chin-Yu [1 ]
Chen, Guan-Yu [1 ]
Hu, Yu-Chen [1 ]
机构
[1] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan
关键词
Baculovirus; Vaccine; Immune responses; Tissue engineering; Cancer therapy; Antiviral therapy; MESENCHYMAL STEM-CELLS; ROTATING-SHAFT BIOREACTOR; GREEN FLUORESCENT PROTEIN; RETRACTED ARTICLE. SEE; AVIAN INFLUENZA-VIRUS; SWINE-FEVER VIRUS; MAMMALIAN-CELLS; RECOMBINANT BACULOVIRUS; SURFACE DISPLAY; IMMUNE-RESPONSES;
D O I
10.1016/j.biotechadv.2011.04.004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Baculovirus infects insects in nature and is non-pathogenic to humans, but can transduce a broad range of mammalian and avian cells. Thanks to the biosafety, large cloning capacity, low cytotoxicity and non-replication nature in the transduced cells as well as the ease of manipulation and production, baculovirus has gained explosive popularity as a gene delivery vector for a wide variety of applications. This article extensively reviews the recent understandings of the molecular mechanisms pertinent to baculovirus entry and cellular responses, and covers the latest advances in the vector improvements and applications, with special emphasis on antiviral therapy, cancer therapy, regenerative medicine and vaccine. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:618 / 631
页数:14
相关论文
共 229 条
[1]   Involvement of the toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus [J].
Abe, T ;
Hemmi, H ;
Miyamoto, H ;
Moriishi, K ;
Tamura, S ;
Takaku, H ;
Akira, S ;
Matsuura, Y .
JOURNAL OF VIROLOGY, 2005, 79 (05) :2847-2858
[2]   Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice [J].
Abe, T ;
Takahashi, H ;
Hamazaki, H ;
Miyano-Kurosaki, N ;
Matsuura, Y ;
Takaku, H .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1133-1139
[3]   Host Innate Immune Responses Induced by Baculovirus in Mammals [J].
Abe, Takayuki ;
Matsuura, Yoshiharu .
CURRENT GENE THERAPY, 2010, 10 (03) :226-231
[4]   Baculovirus Induces Type I Interferon Production through Toll-Like Receptor-Dependent and -Independent Pathways in a Cell-Type-Specific Manner [J].
Abe, Takayuki ;
Kaname, Yuuki ;
Wen, Xiaoyu ;
Tani, Hideki ;
Moriishi, Kohji ;
Uematsu, Satoshi ;
Takeuchi, Osamu ;
Ishii, Ken J. ;
Kawai, Taro ;
Akira, Shizuo ;
Matsuura, Yoshiharu .
JOURNAL OF VIROLOGY, 2009, 83 (15) :7629-7640
[5]   Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery [J].
Airenne, KJ ;
Hiltunen, MO ;
Turunen, MP ;
Turunen, AM ;
Laitinen, OH ;
Kulomaa, MS ;
Ylä-Herttuala, S .
GENE THERAPY, 2000, 7 (17) :1499-1504
[6]   Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells [J].
Aoki, H ;
Sakoda, Y ;
Jukuroki, K ;
Takada, A ;
Kida, H ;
Fukusho, A .
VETERINARY MICROBIOLOGY, 1999, 68 (3-4) :197-207
[7]   Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses [J].
Bai, Bingke ;
Lu, Xinya ;
Meng, Jin ;
Hu, Qinxue ;
Mao, Panyong ;
Lu, Baojing ;
Chen, Ze ;
Yuan, Zhiming ;
Wang, Hanzhong .
MOLECULAR IMMUNOLOGY, 2008, 45 (04) :868-875
[8]   Baculovirus-transduced bone marrow mesenchymal stem cells for systemic cancer therapy [J].
Bak, X. Y. ;
Yang, J. ;
Wang, S. .
CANCER GENE THERAPY, 2010, 17 (10) :721-729
[9]   Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells as Cellular Delivery Vehicles for Prodrug Gene Therapy of Glioblastoma [J].
Bak, Xiao Ying ;
Lam, Dang Hoang ;
Yang, Jingye ;
Ye, Kai ;
Wei, Esther Lee Xing ;
Lim, Sai Kiang ;
Wang, Shu .
HUMAN GENE THERAPY, 2011, 22 (11) :1365-1377
[10]   High Mobility Group Box2 Promoter-controlled Suicide Gene Expression Enables Targeted Glioblastoma Treatment [J].
Balani, Poonam ;
Boulaire, Jerome ;
Zhao, Ying ;
Zeng, Jieming ;
Lin, Jiakai ;
Wang, Shu .
MOLECULAR THERAPY, 2009, 17 (06) :1003-1011